You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

35 Results
Guidelines and Advice
Status: Current
ID: 4-16
Version: 3
May 2025
Drug
Other Name(s): Temodal®
Aug 2025
Drug
Other Name(s): Neupogen®, Grastofil®, Nivestym®, Nypozi®, Filra™
Sep 2025
Drug
Other Name(s): Efudex® Cream , IV generic brands available
Sep 2025
Drug
Other Name(s): Euflex®
Aug 2025
Drug
Other Name(s): Faslodex®
Aug 2025
Drug
Other Name(s): Mekinist®
Jun 2025
Regimen
Intent: Palliative
Funding:
ODB - General Benefit
    fulvestrant
Aug 2025
Regimen
Cancer Type:
Central Nervous System
Intent: Palliative
Funding:
ODB - General Benefit
    temozolomide
Aug 2025
Regimen
Intent: Palliative
Funding:
Exceptional Access Program
    trametinib - As monotherapy in patients with BRAF V600 mutation-positive unresectable or metastatic melanoma, according to specific criteria
Jun 2025
Regimen
Cancer Type:
Gynecologic, 
Ovary
Intent: Palliative
Jul 2025

Pages